| |
 |
|
Class Information
Number: 514/2
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Peptide containing (e.g., protein, peptones, fibrinogen, etc.) doai
Description: Subject matter which contains a protein or its reaction product, e.g., peptides, peptones, fibrinogen, etc., wherein the protein molecule is not degraded to the constituent amino-acids.
Sub-classes under this class:
| Class Number |
Class Name |
Patents |
| 514/14 |
12 to 15 peptide repeating units in known peptide chain |
1,116 |
| 514/13 |
16 to 24 peptide repeating units in known peptide chain |
1,153 |
| 514/19 |
2 peptide repeating units in known peptide chain |
1,321 |
| 514/12 |
25 or more peptide repeating units in known peptide chain structure |
5,604 |
| 514/18 |
3 or 4 peptide repeating units in known peptide chain |
1,598 |
| 514/17 |
5 or 6 peptide repeating units in known peptide chain |
1,072 |
| 514/16 |
7 or 8 peptide repeating units in known peptide chain |
1,048 |
| 514/15 |
9 to 11 peptide repeating units in known peptide chain |
1,375 |
| 514/9 |
Cyclopeptides |
698 |
| 514/8 |
Glycoprotein (carbohydrate containing) |
2,035 |
| 514/6 |
Heavy metal containing (e.g., hemoglobin, etc.) |
451 |
| 514/3 |
Insulin or derivative |
608 |
| 514/5 |
Iodine containing |
42 |
| 514/7 |
Phosphorus containing |
196 |
| 514/21 |
Produced by or extracted from animal tissue |
2,379 |
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7557080 |
Bacillus Cry9 family members |
Jul. 7, 2009 |
| 7557079 |
Metalloprotease proteins |
Jul. 7, 2009 |
| 7557078 |
Morphogen-induced nerve regeneration and repair |
Jul. 7, 2009 |
| 7556835 |
High efficiency protein extraction |
Jul. 7, 2009 |
| 7556821 |
Apparatus and method for transdermal delivery of parathyroid hormone agents |
Jul. 7, 2009 |
| 7556798 |
Highly efficient delivery of a large therapeutic mass aerosol |
Jul. 7, 2009 |
| RE40812 |
Nasal calcitonin formulation |
Jun. 30, 2009 |
| 7553872 |
Compounds and compositions for delivering active agents |
Jun. 30, 2009 |
| 7553819 |
Multivalent inhibitors of serum amyloid P component |
Jun. 30, 2009 |
| 7553812 |
Acyclovir-peptide analogs |
Jun. 30, 2009 |
| 7553811 |
Methods and compositions for modulating immunity |
Jun. 30, 2009 |
| 7553810 |
Lung volume reduction using glue composition |
Jun. 30, 2009 |
| 7553809 |
Fc receptor modulators and uses thereof |
Jun. 30, 2009 |
| 7553494 |
WT1 fusion proteins |
Jun. 30, 2009 |
| 7550441 |
Controlled release polymer nanoparticle containing bound nucleic acid ligand for targeting |
Jun. 23, 2009 |
| 7550427 |
Poly-pegylated protease inhibitors |
Jun. 23, 2009 |
| 7550426 |
Acetylated therapeutic procytotoxins |
Jun. 23, 2009 |
| 7550425 |
Diuretic peptide conjugates |
Jun. 23, 2009 |
| 7550424 |
CA IX-specific inhibitors |
Jun. 23, 2009 |
| 7550423 |
Somatostatin antagonists |
Jun. 23, 2009 |
| 7550154 |
Methods of treatment with drug loaded polymeric materials |
Jun. 23, 2009 |
| 7547675 |
Chemically modified polypeptides |
Jun. 16, 2009 |
| 7547674 |
Methods and compositions for the repair and/or regeneration of damaged myocardium |
Jun. 16, 2009 |
| 7547441 |
PAI-2 conjugates for the treatment and imaging of cancer |
Jun. 16, 2009 |
| 7547436 |
Receptor specific transepithelial transport of therapeutics |
Jun. 16, 2009 |
| 7544666 |
NAP derivatives |
Jun. 9, 2009 |
| 7544664 |
Sequences facilitating penetration of a substance of interest |
Jun. 9, 2009 |
| 7544657 |
Stabilized Exendin-4 compounds |
Jun. 9, 2009 |
| 7544655 |
Haptotactic peptides |
Jun. 9, 2009 |
| 7544654 |
.psi..epsilon.RACK peptide composition and method for protection against tissue damage due to ischemia |
Jun. 9, 2009 |
| 7544653 |
Additive cytoprotective effects of two bioactive regions of pro-opiomelanocortin hormone |
Jun. 9, 2009 |
| 7544375 |
Composition |
Jun. 9, 2009 |
| 7541340 |
Methods for reducing CD36 expression |
Jun. 2, 2009 |
| 7541338 |
Glial mitogenic factors, their preparation and use |
Jun. 2, 2009 |
| 7541337 |
Methods and compositions for the treatment of peripheral artery disease |
Jun. 2, 2009 |
| 7541336 |
Substance fki-1033 and process for producing the same |
Jun. 2, 2009 |
| 7541334 |
Hybrid peptides modulate the immune response |
Jun. 2, 2009 |
| 7541333 |
Angiogenically effective unit dose of FGF-2 and method of use |
Jun. 2, 2009 |
| 7541332 |
Fungal cell wall synthesis gene |
Jun. 2, 2009 |
| 7541331 |
Surfactant treatment regimen |
Jun. 2, 2009 |
| 7541330 |
Conjugates with reduced adverse systemic effects |
Jun. 2, 2009 |
| 7541329 |
Oil body associated protein compositions and methods of use thereof for reducing the risk of cardiovascular disease |
Jun. 2, 2009 |
| 7541328 |
Coupling proteins to a modified polysaccharide |
Jun. 2, 2009 |
| 7541157 |
Method of screening groups of radioactive molecules and applications thereof |
Jun. 2, 2009 |
| 7541154 |
GASP1: a follistatin domain containing protein |
Jun. 2, 2009 |
| 7541044 |
Administration of 5T4 antigen and immune response of cells expressing 5T4 and CEA antigens |
Jun. 2, 2009 |
| 7541028 |
Nanoparticles for monoclonal antibody delivery |
Jun. 2, 2009 |
| 7538180 |
Biologically absorbable coatings for implantable devices based on poly(ester amides) and methods for fabricating the same |
May. 26, 2009 |
| 7538089 |
Anti-inflammatory compounds and uses thereof |
May. 26, 2009 |
| 7538085 |
Peptide deformylase inhibitors as novel antibiotics |
May. 26, 2009 |
|
|
|
